DKCM
BOLD

Davidson Kempner Capital Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Davidson Kempner Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-131,630
Closed -$7.88M – 224
2019
Q4 		$7.88M Buy
+131,630
New +$4.94M 0.18% 99

Davidson Kempner Capital Management's BOLD Position: Q1 2020 in Review

Davidson Kempner Capital Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 131,630 shares — an estimated $7.88M sold.

Davidson Kempner Capital Management first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $7.88M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Davidson Kempner Capital Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 131,630 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $7.88M.
  • Davidson Kempner Capital Management first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Davidson Kempner Capital Management's Audentes Therapeutics, Inc position peaked at $7.88M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Davidson Kempner Capital Management's 13F filing for Q1 2020, filed 15 May 2020.